Megestrol Acetate
Megestrol Acetate is a pharmaceutical drug with 46 clinical trials. Currently 6 active trials ongoing. Historical success rate of 78.1%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
26
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
25 of 35 finished
28.6%
10 ended early
6
trials recruiting
46
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
Clinical Trials (46)
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer
Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Phase II Study of Everolimus Beyond Progression
A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 46